A randomised, parallel-group, open-label, multinational trial comparing the efficacy and safety of insulin detemir (Levemir(RM)) versus human insulin
Phase of Trial: Phase III
Latest Information Update: 08 Jun 2016
At a glance
- Drugs Insulin detemir (Primary) ; Insulin
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 14 Jun 2013 Status changed from active, no longer recruiting to completed as reported by United Kingdom Clinical Research Network record.
- 07 Nov 2009 Novo Nordisk added as trial sponsor as reported by United Kingdom Clinical Research Network record.
- 07 Apr 2009 New trial record